Abwi is about to complete the US $63 billion acquisition of Erjian's business in two parts

On January 8, aberway announced that it would create a new global business company, Allergan aesthetics, after the completion of the acquisition, which is expected to be completed in the first quarter of this year Erjian aesthetics will operate as a new global specialized company, mainly leading medical beauty products, including Botox medical beauty products, juvederm, coolsculping, etc The company's global business headquarters will be located in erwan City, California, which is now in the charge of Carrie strom, senior vice president of American medical beauty of Elkem After the acquisition, she will become senior vice president of Elkem and President of Elkem aesthetics, responsible for the global business of the new company, and report directly to Richard A Gonzalez, President and CEO of Elkem While Elgin's eye care and specialty medicine business (including Botox medical products, central nervous system, women's health and digestive products) will be integrated into the existing organizational structure of Elgin According to Elgin, several relevant directors of Elgin have accepted new positions in the future According to today's announcement, Richard A Gonzalez will continue to be chairman and CEO of the new company after the merger, and Carlos Alban will continue to be vice chairman and chief commercial officer On June 25 last year, abbvie and Allergan announced that the two companies had signed a final transaction agreement, under which they would acquire eljian in the form of cash and stock transactions, with a value of about $63 billion based on the closing price of $78.45 of common shares on June 24.